Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED

NCT04338828 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
47
Enrollment
OTHER
Sponsor class

Stopped Absence of patients meeting criteria following initial COVID surge. DMSB recommended analysis of results to date and early closure.

Conditions

Interventions

Sponsor

Massachusetts General Hospital